Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: What is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis

Anna Maria Peri,Mark D Chatfield,Weiping Ling,Luis Furuya-Kanamori,Patrick N A Harris,David L Paterson

DOI: https://doi.org/10.1093/cid/ciae234

IF: 20.999

2024-04-28

Clinical Infectious Diseases

Abstract:Background Evidence about the clinical impact of rapid diagnostic tests (RDT) for the diagnosis of bloodstream infections is limited, and whether RDT are superior to conventional blood cultures (BC) embedded within antimicrobial stewardship programs (ASP) is unknown. Methods We performed network meta-analyses (NMA) using results from studies of patients with bloodstream infection with the aim of comparing the clinical impact of RDT (applied on positive BC broth or whole blood) to conventional BC, both assessed with and without ASP with respect to mortality, length of stay (LOS) and time to optimal therapy (TOT). Results Eighty-eight papers were selected, including 25,682 patient encounters. There was an appreciable amount of statistical heterogeneity within each meta-analysis. The NMA showed a significant reduction in mortality associated with the use of RDT + ASP vs BC alone (OR 0.72, 95%CI 0.59, 0.87) and with the use of RDT + ASP vs BC + ASP (OR 0.78 95%CI 0.63, 0.96). No benefit in survival was found associated with the use of RDT alone nor with BC + ASP compared to BC alone. A reduction in LOS was associated with RDT + ASP vs BC alone (0.91, 95%CI 0.84, 0.98) while no difference in LOS was shown between any other groups. A reduced TOT was shown when RDT + ASP was compared to BC alone (-29 h, 95%CI -35, -23), BC + ASP (-18 h, 95%CI -27, -10) and to RDT alone (-12 h, 95%CI -20, -3). Conclusion The use of RDT + ASP may lead to a survival benefit even when introduced in settings already adopting effective ASP in association with conventional BC.

immunology,infectious diseases,microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the clinical effect of rapid diagnostic tests (RDT) in the management of blood infections. In particular, compared with traditional blood culture (BC) combined with antimicrobial stewardship programs (ASP), whether RDT can improve patients' clinical outcomes more effectively. Specifically, the study focuses on the following aspects:

1. **Mortality**: Evaluate whether the use of RDT plus ASP can significantly reduce patient mortality compared with using only BC or BC plus ASP.
2. **Length of stay (LOS)**: Examine whether RDT plus ASP can shorten the patient's length of stay in the hospital.
3. **Time to optimal treatment (TOT)**: Analyze whether RDT plus ASP can achieve antimicrobial treatment for the final pathogen more quickly.

Through network meta - analysis (NMA), the researchers compared four different intervention strategies:
- Using only BC
- BC plus ASP
- Using only RDT
- RDT plus ASP

The main purpose of the study was to determine whether RDT still has additional clinical benefits in medical institutions where effective ASP has been implemented, especially in terms of reducing mortality and shortening the length of hospital stay.